JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $75 at JPMorgan on Favorable Near-Term Outlook
-
-
-
-
-
-
-
Cytokinetics Announces Closing of Public Offering of Common Stock
-
-
-
-
-
-
-
Wall Street bullish on Cytokinetics (CYTK) following positive trial results
-
-
-
-
-
-
-
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Pre-Open Stock Movers 06/02: (NPSP) (PL) (BRCM) Higher; (PBYI) (MTZ) (CYTK) Lower (more...)
-
-
-
-
-
-
-
Morning Movers 01/11: PEIX, EPCT, MMR, TUES, KTII Higher; CYCC, LUNA, IOC, ASBC, HOGS Lower
-
295,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

